InvestSMART

Invex Therapeutics Ltd (ASX: IXC) - Announcements

- Current share price for IXC : $0.115

ASX company news and announcements for Invex Therapeutics Ltd (IXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invex Therapeutics Ltd (IXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invex Therapeutics Ltd (IXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invex Therapeutics Ltd (IXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Quarterly Activities/Appendix 4C Cash Flow Report 19 Apr 2022 8:49AM $0.750 $0.115 fallen by 84.67%
$9 March Appendix 4C and Investor Conference Call Details 13 Apr 2022 9:42AM $0.715 $0.115 fallen by 83.92%
$9 Executive Director Agreement 1 Apr 2022 3:46PM $0.620 $0.115 fallen by 81.45%
$9 Invex to Present at Upcoming Tech Biotech Broker Briefing 22 Mar 2022 8:54AM $0.565 $0.115 fallen by 79.65%
$9 Half Yearly Report and Accounts 22 Feb 2022 3:55PM $0.575 $0.115 fallen by 80%
$9 Upcoming Presentations at 48th Annual NANOS Meeting 10 Feb 2022 9:53AM $0.620 $0.115 fallen by 81.45%
$9 New Executive Director and Chairman Agreements 31 Jan 2022 8:54AM $0.610 $0.115 fallen by 81.15%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 24 Jan 2022 9:36AM $0.695 $0.115 fallen by 83.45%
$9 Notice of Investor Call and Appendix 4C 21 Jan 2022 10:02AM $0.680 $0.115 fallen by 83.09%
$9 Change of Registry Address 20 Dec 2021 2:48PM $0.680 $0.115 fallen by 83.09%
$9 UK R&D Tax Rebate 20 Dec 2021 11:53AM $0.670 $0.115 fallen by 82.84%
$9 Appointment IIH EVOLVE Phase III Trial Steering Group Chair 17 Dec 2021 10:26AM $0.700 $0.115 fallen by 83.57%
$9 Results of Meeting 25 Nov 2021 8:20PM $0.630 $0.115 fallen by 81.75%
$9 Chairman's Address to Shareholders at AGM 25 Nov 2021 6:51PM $0.630 $0.115 fallen by 81.75%
$9 Withdrawal of AGM Resolutions 23 Nov 2021 4:15PM $0.630 $0.115 fallen by 81.75%
$9 Invex to Present at Bell Potter Healthcare Conference 10 Nov 2021 4:21PM $0.710 $0.115 fallen by 83.80%
$9 Notice of Webinar & Investor Presentation 4 Nov 2021 2:41PM $0.740 $0.115 fallen by 84.46%
$9 Global Phase 3 Trial of Presendin to Launch in Q4 2021 4 Nov 2021 9:12AM $0.655 $0.115 fallen by 82.44%
$9 Notice of Annual General Meeting/Proxy Form 25 Oct 2021 9:38AM $0.735 $0.115 fallen by 84.35%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 20 Oct 2021 8:35AM $0.720 $0.115 fallen by 84.03%
$9 Presentation at EANS 2021 Congress 8 Oct 2021 9:04AM $0.680 $0.115 fallen by 83.09%
$9 Date of AGM and Closing Date for Director Nominations 30 Sep 2021 3:19PM $0.700 $0.115 fallen by 83.57%
$9 Notice of Investor Call and Presentation 27 Sep 2021 10:06AM $0.680 $0.115 fallen by 83.09%
$9 Exclusive Collaboration and Manufacturing Agreement 27 Sep 2021 9:58AM $0.680 $0.115 fallen by 83.09%
$9 Trading Halt 24 Sep 2021 9:15AM $0.680 $0.115 fallen by 83.09%

151 - 175 of 299 results

Page 7 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.